The Pennant Group, Inc. · NASDAQ:PNTG
Steik Jason Paul sold 1,394 The Pennant Group, Inc. shares (Form 4)
Traded Aug 6, 2026 · Filed Aug 10, 2026
On Aug 6, 2026, Steik Jason Paul (Chief Clinical Officer) sold 1,394 The Pennant Group, Inc. shares at US$38.52 for US$53,697 under a trading plan, leaving 15,106 shares. Filed Aug 10, 2026 (Form 4).
- Sold
- 1,394 shares
- Price
- US$38.52
- Value
- US$53,697
- Holding after
- 15,106 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Clinical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | Common Stock | Sale | 1,394 | US$38.52 | 15,106 | Direct |